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Abstract
Background: Surface functionalization of orthopedic implants with pharmaceutically active agents is a modern
approach to enhance osseointegration in systemically altered bone. A local release of strontium, a verified bone
building therapeutic agent, at the fracture site would diminish side effects, which could occur otherwise by oral
administration. Strontium surface functionalization of specially designed titanium-niobium (Ti-40Nb) implant alloy
would provide an advanced implant system that is mechanically adapted to altered bone with the ability to
stimulate bone formation.
Methods: Strontium-containing coatings were prepared by reactive sputtering of strontium chloride (SrCl2) in a
self-constructed capacitively coupled radio frequency (RF) plasma reactor. Film morphology, structure and composition
were investigated by scanning electron microscopy (SEM), time of flight secondary ion mass spectrometry (ToF-SIMS)
and X-ray photoelectron spectroscopy (XPS). High-resolution transmission electron microscopy (HR-TEM) was used for
the investigation of thickness and growth direction of the product layer. TEM lamellae were prepared using the focused
ion beam (FIB) technique. Bioactivity of the surface coatings was tested by cultivation of primary human osteoblasts and
subsequent analysis of cell morphology, viability, proliferation and differentiation. The results are correlated with the
amount of strontium that is released from the coating in biomedical buffer solution, quantified by inductively coupled
plasma mass spectrometry (ICP-MS).
Results: Dense coatings, consisting of SrOxCly, of more than 100 nm thickness and columnar structure, were prepared.
TEM images of cross sections clearly show an incoherent but well-structured interface between coating and substrate
without any cracks. Sr2+ is released from the SrOxCly coating into physiological solution as proven by ICP-MS analysis.
Cell culture studies showed excellent biocompatibility of the functionalized alloy.
Conclusions: Ti-40Nb alloy, a potential orthopedic implant material for osteoporosis patients, could be successfully
plasma coated with a dense SrOxCly film. The material performed well in in vitro tests. Nevertheless, the Sr
2+ release must
be optimized in future work to meet the requirements of an effective drug delivery system.
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Background
Titanium and its alloys are well established biomaterials
for the production of load-bearing implants for hard tis-
sue replacement and fracture stabilization. They offer
beneficial mechanical properties and develop a stable
passivating oxide film that ensures excellent biocompati-
bility and good corrosion resistance [1]. Despite of their
successful use as surgical implants the mechanical and
surface properties still need to be improved to meet the
specific challenges that orthopedics and traumatology
are facing. Key weaknesses of currently used α and α/β-
type titanium-based implants are their high stiffness
mismatch to bone [2] and their biocompatibility, which
can be increased further by surface modification to fi-
nally enhance osseointegration [3]. As in the future a
continuous rise of population’s life expectancy is ex-
pected, more patients will suffer from age-related or
post-menopausal osteoporosis or its secondary forms.
These bone disorders negatively affect mineral density,
fragility [4, 5] and regenerative ability of bone [6]. There-
fore, it is an important aim to develop advanced metallic
implants that are mechanically adapted to the weakened
bone structure and ensure fast bone integration by
modified surface characteristics [3].
Beta-type Ti-40Nb alloy is a very promising implant ma-
terial for the treatment of bone fractures because it ex-
hibits a low elastic modulus combined with moderate
strength [7]. Besides that, it has been shown that niobium
leads to an outstanding corrosion resistance of the passiv-
ating oxide film [8]. While this is a major advantage on
the one hand, it makes standard surface treatment proto-
cols for metallic implants ineffective on the other hand, so
that alternative methods were exploited [9].
Strontium cations (Sr2+) are successfully used for the
medical treatment of patients with osteoporosis by oral
administration of strontium ranelate. In vitro and in vivo
studies showed that strontium ions are able to stimulate
new bone formation and inhibit excessive bone resorp-
tion [10], which is occurring in osteoporotic bone and
caused by a characteristic imbalance between bone-
building osteoblasts and bone-resorbing osteoclasts [11].
The success of strontium as an anti-osteoporotic drug
suffered a setback in 2014, when the European Medi-
cines Agency recommended a restricted use of stron-
tium ranelate due to its adverse effects, which include an
increased risk of serious cardiac disorders [12]. To
minimize this risk, a locally administered release of
strontium, for example by coating of surgical implants,
would be highly beneficial [13]. Numerous studies found
an increased biocompatibility and upregulation of osteo-
genesis related genes in vitro [14–16] and an effectively
improved implant osseointegration in vivo, in bone-
healthy [17, 18] and recently in ovariectomized rats [19].
The spatial dispersion of the therapeutic agent Sr2+ in
rat bone with time in vivo was recently described by
Rohnke et al. [20]. It was shown that the Sr2+ release
and transport from a biomaterial into bone is a usefull
concept, which can be mathematically described with
the help of Ficks laws of diffusion.
Methods for preparation of strontium-releasing im-
plant coatings involve hydro-thermal synthesis routes
[15–17], Sr-substituted hydroxyapatite coating [21, 22],
NaOH treatment followed by strontium acetate treat-
ment [14], electrolytic deposition techniques [23, 24]
and non-reactive magnetron sputtering [18, 19]. For
optimum medical performance of such coatings it is as-
sumed, that ionic strontium needs to be released con-
tinuously over a period of several weeks while the
pharmaceutical effect threshold is in the range of
0.10 mM and defined by the serum strontium level of
postmenopausal osteoporosis patients that were treated
with strontium ranelate [25]. However, an initial burst
release of strontium after implantation is also unwanted
to reduce the risk of a short-time toxic strontium level
[18]. In recent approaches such a regulated strontium
release was demonstrated by chelation into folic acid
[26] and introduction of topographical structures [27].
In the present study, strontium-containing thin films
are deposited on Ti-40Nb substrates by reactive sputtering
of strontium chloride in a radio frequency (RF) oxygen
discharge. The chemical composition and morphology of
films were characterized by scanning electron microscopy
(SEM), X-ray photoelectron spectroscopy (XPS), second-
ary ion mass spectrometry (SIMS) and transmission elec-
tron microscopy (TEM). By immersion of the coated
substrates in Tris-buffered saline (TBS) the strontium re-
lease of the thin films was determined using inductively
coupled plasma mass spectrometry (ICP-MS). Finally, the
biological response of primary human osteoblasts to these
films was evaluated in vitro.
Methods
Ti-40Nb sample preparation
A beta-phase Ti-40Nb rod with a diameter of 12 mm
was prepared by arc melting and cold crucible casting
followed by homogenization treatment, as described in
detail in reference [28]. Discs with a thickness of 0.7 mm
were prepared by cutting the rod using an IsoMet 5000
linear precision saw (Buehler, Switzerland) equipped
with a SiC cut-off wheel (Struers, Denmark). Ti-40Nb
discs were ground with bound diamond particles
(15 μm) using a Phoenix 4000 grinding and polishing
machine (Buehler). The discs were polished with a 9 μm
diamond suspension (MetaDi, Buehler) and subsequently
fine polished with a 4:1 colloidal SiO2 (20 nm Master-
Met2, Buehler)/H2O2 (35% HYPROX®, Evonik,
Germany) mixture. Finally, the mirror-polished discs
were cleaned in acetone, demineralized water and pure
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ethanol using an ultrasonic bath for 10 min in succes-
sion. The samples were stored in ethanol until strontium
deposition was performed.
Plasma setup
All deposition experiments were conducted using a self-
built plasma setup for excitation of capacitively coupled
RF plasma, already introduced in [29] (Fig. 1). Two disc-
shaped electrodes of same size were arranged parallel to
each other inside a spherical vacuum chamber (approx.
35 cm in diameter), all made of stainless steel. The dis-
tance between the electrodes was 3.5 cm, and they are
approx. 8.0 cm in diameter. The lower electrode was
heatable and attached to the grounded vacuum chamber
to ensure adjustment of high self-bias values. The top
electrode was powered by an RF generator (PFG RF 300,
Trumpf Hüttinger Elektronik, Germany) and matching
network system (PFM 1500 A, Trumpf Hüttinger Elek-
tronik), operating at 13.56 MHz.
One special feature of the top electrode is a removable
lower side that is coated with a SrCl2 layer (details to the
coating process are described below), therefore acting as
strontium-containing target for the sputtering process.
For supply of the process gases (Ar, O2, both 99.999%), a
system of electropneumatic valves (EVI 105 P, Pfeiffer
Vacuum, Germany) and mass flow controllers (MKS In-
struments, US) was flanged to the vacuum chamber as
well as a manometer (Baratron, MKS Instruments, US)
to monitor overall gas pressure (Fig. 2).
For evacuation of the vacuum chamber a rotary vane
pump (Duo 10, Pfeiffer Vacuum, Germany) was at-
tached. The sample temperature was adjusted using an
Eurotherm controller (Model 2416, Schneider Electric,
France) and a type K thermocouple (Thermocoax, France)
that was located beneath the lower electrode. Electropneu-
matic valve control, gas flow and pressure control, RF gen-
erator and temperature control were connected to a
computer to automatize the deposition process using Lab-
VIEW (National Instruments, US) software.
SrCl2 target preparation
A SrCl2 layer was prepared onto the removable part of
the top electrode (hereinafter referred to as “target elec-
trode”) by dropcasting of a saturated solution of SrCl2
(99.9%) and a 1:1 mixture of H2O and pure ethanol. The
target electrode was placed on a heating plate, fully cov-
ered with the solution and subsequently heated to speed
up solvent evaporation.
Strontium functionalization by reactive sputtering
After placing the polished Ti-40Nb samples on the
lower, grounded electrode, the plasma chamber was
evacuated to a pressure of p = 1 Pa several times for
complete removal of residual water inside the vacuum
chamber including the hygroscopic SrCl2 target. Once
pumped, the reactor was continuously flooded with a
mixture of 0.25 sccm O2 and 0.68 sccm Ar resulting in
an overall gas pressure of 21 Pa. Strontium deposition
was carried out at room temperature with constant RF
power of P = 100 W and variable dc bias voltage for
t = 2000 s. Afterwards this procedure was repeated once
more. After every deposition process both electrodes
were polished with a polishing paper (grain size 4000)
and cleaned with acetone to remove passivating oxide
films that have been formed due to the oxygen plasma
exposure.
Strontium film characterization
SEM images of the strontium film surface were taken with
a MERLIN field emission scanning electron microscope
(Carl Zeiss Microscopy, Germany) using an acceleration
voltage of 3.0 kV at 4 mm working distance. EDX mea-
surements were carried out with an Oxford Instruments
(Abingdon, UK) silicon drift X-Max 50 detector.
For TEM investigations of film morphology (thick-
nesses, roughness), homogeneity and grain structure thin
cross section lamellae were prepared using the focussed
ion beam (FIB) technique. A thin slice perpendicular to
the sample surface was cut out in a Zeiss Cross Beam
1540 XB (Carl Zeiss Microscopy) with a 30 keV fine fo-
cussed gallium ion probe. This lamella was in situ trans-
ferred and welded on a special copper grid by use of the
electron beam under SEM control. The final lamella
thickness of less than 100 nm was reached by thinning
with a gallium ion probe of lower energy (ca. 5 keV). To
reduce the amorphization and the gallium implantation
a protection bar of hydrocarbon and hydrocarbon
Fig. 1 Plasma setup; Schematic sketch of the capacitively coupled
RF plasma setup
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containing platinum was deposited onto the sample sur-
face at the cutting position before starting the proced-
ure. For the TEM analyses we used a TEM/STEM
microscope Tecnai F30 ST (FEI Company, US) equipped
with Ametek/EDAX (US) windowless SDD for energy
dispersive X-ray spectroscopy (EDXS) and Gatan im-
aging filter 200 for electron energy loss spectroscopy
(EELS). The measurements were done using an acceler-
ation voltage of 300 kV reaching a resolution limit of
better than 0.2 nm.
The elemental composition of the Sr-coating was ana-
lyzed by ToF-SIMS depth profiling using a ToF-SIMS 5-
100 machine of IONToF company (Germany). Cation
depth profiles were generated by sputtering with 1 keV O2
+
ions in combination with surface analysis using 25 keV Bi+
primary ions. The primary ion gun was operated in high
current bunched mode with a mass resolution m/
Δm > 6900 for Ti+ (m/z 47.95). For anion depth profiling
0.5 keV Cs+ ions were used. Data were evaluated with Sur-
faceLab 6.7 software (IONToF company). After depth pro-
filing the sputter craters were measured with a confocal
microscope PLu neox 3D (Sensofar Group) to calibrate
the sputter time axis. For calibration of the sputter time
axis the assumption was made that the sputter yields in
the film and in the bulk material are the same.
The surface composition was analyzed by XPS with a
PHI Versaprobe 2 instrument (Physical electronics, US)
equipped with a monochromatized Al k-alpha source
with 1486.6 eV. For depth profiling the instrument is
equipped with an Ar+ ion sputter gun. Charge
neutralization was conducted with ~1 eV electrons and
~10 eV Ar+ ions in parallel. The sample was excited with
a 200 μm diameter X-ray beam (50 W) and the data was
measured with an analyzer pass energy of 23.5 eV and a
stepsize of 0.2 eV. For depth profiling, we sputtered with
1 kV beam energy and a raster size of 2 mm × 2 mm for
2 min between each measurement.
Determination of strontium ion release
For analysis of strontium ion release a 0.05 M Tris-HCl
buffer with pH 7.6 containing 0.15 M sodium chloride
was prepared by dissolving a TBS BioUltra tablet
(Sigma-Aldrich, US) in 500 ml demineralized water. Due
to CO2 uptake from air the pH decreased slightly after
starting the experiment to physiological conditions. Sr
functionalized Ti-40Nb samples were prepared and
immersed in 5 ml Tris-HCl buffer per sample for one
day. For quantitative analysis of the strontium content
the buffer solutions were weighted and mixed with con-
centrated nitric acid at 60 °C. The solutions were diluted
with purified water to achieve a suitable concentration
range for mass spectrometric analysis. ICP-MS analysis
was conducted with an ELEMENT 2 machine from
Thermo Fisher Scientific (Germany). Calibration was
Fig. 2 Technical mapping; Technical mapping of the RF plasma equipment
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done by addition of standard Sr2+ solutions with 50, 100,
500, 1000 and 5000 ppt. The strontium release experi-
ment was reproduced three times.
In vitro biological characterization
Biocompatibility of the Sr-functionalized surface was
studied in vitro using primary human osteoblasts (hOB).
The cells were isolated from spongious bone of human
femoral heads derived from two osteoarthritic patients
(female, age: 56 and 75 years, moderate to servere state
of osteoarthritis) undergoing total hip replacement at
the university hospital‚ Carl Gustav Carus‘ Dresden after
obtaining informed consent. The ethics commission of
Technische Universität Dresden approved the applica-
tion of hOB for in vitro experiments (no. EK
262092009). The cells were expanded in α-MEM con-
taining 15% fetal calf serum (FCS), 2 mM L-glutamine
(L-glu), 100 U/ml penicillin and 100 mg/ml strepto-
mycin (pen/strep) (all from Biochrom, Germany) until
passage 3. Sr-functionalized samples (Sr-Ti40Nb) and, as
reference, unfunctionalized samples (Ti40Nb) were
seeded with 2 × 104 hOB per disc (d = 12 mm,
h = 0.7 mm) and cultivated in α-MEM containing 9%
FCS, L-glu, pen/strep as well as 10−7 M dexamethasone,
10 mM β-glycerophosphate and 0.05 mM ascorbic acid
2-phosphate (all from Sigma-Aldrich). After 1, 7, 14 and
21 days of cultivation, samples were collected for bio-
chemical and microscopic analysis.
Cell viability and proliferation were assessed by meas-
urement of the intracellular lactate dehydrogenase
(LDH) activity and the DNA content; osteogenic differ-
entiation was evaluated by quantification of alkaline
phosphatase (ALP) activity. The samples, frozen after
cell culture, were thawed and incubated for 50 min in
1% Triton X-100/PBS on ice; cell lysis was supported by
10 min ultrasonication. LDH activity in the lysates was
analysed using the CytoTox 96® Non-Radioactive Cyto-
toxicity Assay (Promega, USA), and the DNA content
was determined using the QuantiFluor® Assay (Promega),
both according to the manufacturer’s instructions. The
measured values were correlated with the cell number
using a calibration series. For quantification of the ALP
activity, the lysates were incubated with p-nitrophenyl
phosphate (Sigma-Aldrich) in substrate buffer (0.1 M
diethanolamine, 1% Triton X-100, 1 mM MgCl2, pH 9.8)
at 37 °C for 30 min, followed by absorbance measure-
ment at 405 nm. The amount of p-nitrophenolate (pNp)
produced by ALP in the cell lysate was calculated using
a calibration line. ALP activity was normalized to the cell
number to express specific ALP activity (μmol pNp/
30 min/106 cells). Cell distribution and morphology on
the samples were investigated by fluorescence micros-
copy: After fixation in 3.7 wt% formaldehyde, actin cyto-
skeleton and nuclei of the cells were stained by
AlexaFluor 488® phalloidin and DAPI (both from Invi-
trogen, USA), respectively. Fluorescence microscopy was
performed using a Keyence BZ-X700 (Keyence Cooper-
ation, Japan).
Results and discussion
Strontium oxide chloride film characterization
Figure 3 shows a typical SEM image of the film surface
after the strontium deposition process. A dense thin film
with a very smooth surface was produced whereas add-
itional μm-sized particles were present on the surface.
An analysis of the particle composition by EDX (not
shown) revealed that they contain strontium, fluorine
and chlorine. The origin of this surface contamination is
discussed at the end of this section.
Figure 4 shows a cross-sectional TEM image of the
layer structure after strontium deposition. The thin Sr-
containing film, from here termed as SrOxCly film, is
130 nm thick including an interlayer of about 10 nm dir-
ectly above the substrate surface. This interlayer is very
likely a passivating Ti-Nb oxide that forms spontan-
eously after the polishing procedure. The SrOxCly film is
composed of nanocrystalline grains that are preferably
configured in columns with less than 10 nm in width
and oriented in growth direction of the layer. The sur-
face roughness of the deposited film is less than 5 nm. A
high resolution image of the interface region between
substrate and Sr-film in Fig. 5 shows no epitaxial rela-
tions between both phases. Although the TEM image re-
veals a dense and completely adhering coating layer it
cannot be excluded that microcracks or spalling occurs,
if too much bending is carried out in a convex way.
In Fig. 6 EDX spectra of three different regions inside
the layer structure are depicted. As expected, titanium
and niobium signals emerged in the Ti-40Nb substrate
region. At the thin interlayer a higher amount of oxygen
was found, compared to the substrate region. This con-
firms the above mentioned assumption that a passivating
oxide film forms an interlayer. A considerable amount of
fluorine was found, possibly emerging from condensa-
tion of gaseous fluorine compounds inside the vacuum
chamber before the deposition process. Potential fluor-
ine sources are Teflon and MACOR® parts inside the
vacuum chamber and volatile compounds from the vac-
uum pump oil or vacuum grease.
Inside the strontium film, mainly strontium, oxygen,
chlorine and iron impurities were detected. We conclude
that the reaction of SrCl2 to SrO in the oxygen discharge
is incomplete and that iron was also sputtered from the
target electrode, causing this element composition. No
fluorine signal was found within the SrOxCly film so that
fluorine incorporation during strontium deposition is rela-
tively low. As the detection limit of TEM-EDXS is 1–
2 at.%, this does not exclude smaller fractions of fluorine.
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As an additional tool for phase characterization we used
X-ray diffraction. The obtained data is depicted in the
Additional file 1. Unfortunately, the count rate is poor and
no well-grounded conclusion is possible. Nevertheless, the
small reflexes could assigned to a SrOxCly phase.
Representative ToF-SIMS anion and cation depth pro-
files of strontium coated Ti-40Nb are depicted in Fig. 7.
As halogens and halogen-containing fragments, such as
F−, Cl− or SrF− ions are easily ionized, their signal inten-
sity reaches the saturation limit of the secondary ion de-
tector. Therefore, we used specific halogen-containing
signals (e.g. 37Cl−, F2
−) to determine a reliable depth pro-
file of an element species, especially at interfaces. In case
of the cations, the Sr+ secondary ion signal was oversa-
turated. From the two depth profiles, we conclude that
the deposited strontium film is chemically homogeneous
and contains SrO and SrCl2 as well as traces of FexOy.
This is in agreement with the reported TEM results.
As mentioned before, F− and SrF− signals in the anion
depth profile are oversaturated (not shown in Fig. 7)
from the beginning of the spectra. By monitoring the F2
−
and F+ signals, we found that the highest fluorine con-
centration is located at the interlayer. There are also
fluorine impurities inside the strontium film, but it is
safe to assume that their concentration was below




−) reach a maximum inten-
sity at the interlayer, which is also in agreement with the
TEM results. At higher depth, mainly substrate signals
(Ti+, Nb+) were detected. As observed in [30] the mono-
oxygen fragments TiO− and NbO− are characteristic sig-
nals in pure Ti-40Nb samples. Due to a high oxygen
solubility combined with a high oxygen affinity of the
pure metals, these fragments were formed during sec-
ondary ion emission.
XPS measurements were carried out to obtain more
accurate chemical information of the coating. In Fig. 8 a
sputter depth profile of the SrOxCly coated Ti-40Nb
sample is shown. We measured detail spectra of C1s,
O1s, Cl2p, F1 s, Fe2p, Nb3d, Sr3d and Ti2p. The depth
Fig. 3 SEM image; Representative scanning electron microscopy image of a coated surface after reactive sputtering of SrCl2 in Ar/O2 plasma
(room temperature P = 100 W, 0.25 sccm O2, 0.68 sccm Ar, t = 2 × 2000 s)
Fig. 4 TEM image cross section; Cross section TEM brightfield image of the layer stack showing the thicknesses of the Sr-containing film and
interface as well as their crystallinity
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profile supports the findings of the ToF-SIMS and TEM
measurements, even though the profile is not as sharp
due to a larger analysis spot and a less defined sputter
crater. The particles on the surface (Fig. 3) deteriorate
the XPS depth resolution. The strontium Sr3d signal is
present as SrCO3 (only on the surface due to reaction
with CO2 and water from the lab air). SrF2, SrCl2 and
SrO, correspond well to the respective signals of C1s,
O1s, Cl2p and F1 s. The SrF2 is a contamination from
the thin film deposition process present as small spots
on the surface (as shown from SEM/EDXS). Since the
XPS spot size is much wider than the SrF2 spots the sig-
nal superimposed with the SrOxCl>y film. The film itself
consists mainly of SrO and SrCl2. Iron is present as an-
other contamination from the deposition process and
thus correlates with the strontium signal. The titanium
and niobium signals are not present at the surface, indi-
cating a homogeneous film without cracks or pinholes.
During depth profiling both the Nb3d as well as the
Ti2p signal appear in the fully oxidized state and are re-
duced to the metal state with ongoing depth profiling.
Due to the fitting procedure and background function
used, the titanium amount is underestimated. Thus, the
stoichiometry at the end of the sputter process is [Ti]/
[Nb] = 56/44 instead of the expected atomic ratio of
about 74/26. The differing atomic ratio for the investi-
gated alloy in XPS spectra is discussed in detail in [31].
Strontium ion release
Preliminary studies at different immersion times re-
vealed that strontium is almost completely released into
physiological solution after 1 day. By ICP-MS analysis an
Fig. 5 HRTEM image; High resolution TEM image of the interfacial
area. The film does not show epitaxial relations to the interface
Fig. 6 TEM images and EDX spectra; (a) TEM brightfield image and EDX spectra acquired from the marked areas (substrate, interface, Sr film). (b)
X-ray energy range 0 … 7000 eV, (c) X-ray energy range 200 … 800 eV
Göttlicher et al. Biomaterials Research  (2017) 21:18 Page 7 of 11
average Sr2+ concentration of 0.05 mM in the buffer so-
lution was quantified. This value is close to the pharma-
ceutical effect threshold of 0.10 mM for osteoblast
activation [10]. In another study Schumacher et al. re-
ported an optimal strontium concentration of 0.01–
0.10 mM for stimulation of human-bone-marrow-de-
rived mesenchymal stem cell proliferation and osteo-
genic differentiation in vitro [32]. However, in contrast
to our material, Schumacher et al. tested strontium-
modified calcium phosphate bone cements that continu-
ously release 0.03–0.07 mM Sr2+ over 20 days. Therefore
we conclude that our coating releases enough strontium
to stimulate osteoblastic activity, but modifications are
required to generate a continuous release. However, in
an in vivo environment we have to deal with more com-
plex interactions, e.g. higher strontium concentrations
around the implant region because of a lower liquid
amount per area that is in contact with the implant.
Additionally, adsorbed proteins may block the strontium
release. ToF-SIMS analysis of the Ti-40Nb surface after
the release experiment revealed only traces of residual
strontium. Obviously, the produced coating dissolves
quickly, generating an initial burst release of strontium.
To produce applicable coatings with optimal strontium
release kinetics, it is important that the strontium
amount is higher while the coating dissolves with a
slower rate and over a longer period. Possible methods
to improve the release characteristics of the coating will
be the deposition of a less water soluble strontium com-
pound (e.g. strontium phosphate [33]) or the deposition
into porous Ti-40Nb implants that might be inserted
directly into bone defects [34].
Biological response of human osteoblasts to SrOxCly-
coated Ti-40Nb
For probing the biological response human osteoblasts
(sustained from osteoarthritis patients) were cultivated
on the surface of SrOxCly-coated Ti-40Nb (Sr-Ti40Nb
in Fig. 9) and unmodified Ti-40Nb samples (Ti40Nb
in Fig. 9). On both surfaces, the cells showed the typical
spreading and cytoskeletal organization 1 day after seeding
and their number increased strongly during further culti-
vation (Fig. 9). Both, measurements of the LDH activity
(related to the number of viable cells) and the DNA con-
tent (reflecting the total cell number) demonstrated an in-
crease of the cell number over time, which was
significantly higher on the strontium-modified samples in
the first experiment with hOB from donor 1 (Fig. 10).
However, in a second experiment with cells from donor 2,
no significant differences were determined between Sr-
Ti40Nb and Ti40Nb (data not shown). The activity of the
osteoblastic marker ALP increased during the cultivation
period of 21 days on both surfaces. However, no signifi-
cant difference between Sr-Ti40Nb and Ti40Nb was ob-
served (Fig. 10).
The results show excellent biocompatibility of the
coating. Because of initial burst release no continuous
Fig. 7 TOF SIMS data; ToF-SIMS depth profiles of the SrOxCly coated Ti-40Nb sample. In a) the depth profile obtained from secondary cations is
depicted. In b) the depth profile obtained from secondary anions is depicted. SrOxCly was deposited at room temperature, P = 100 W, 0.25 sccm
O2, 0.68 sccm Ar, t = 5 h
Fig. 8 XPS data; XPS depth profile of the SrOxCly coated Ti-40Nb
sample. SrOxCly was deposited at room temperature, P = 100 W, 0.25
sccm O2, 0.68 sccm Ar, t = 5 h
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Fig. 9 Results cell culture fluorescence micographs; Fluorescence micrographs of hOB cultured on SrOxCly coated Ti-40Nb samples (a, c) and
uncoated Ti-40Nb samples (b,d) for 1 and 21 days, respectively (dual staining of cell nuclei with DAPI (blue) and of actin cytoskeleton with
phalloidin (green); scale bar = 100 μm)
Fig. 10 Statistics cell culture data; Cell number increase and osteogenic differentiation of hOB cultured on SrOxCly-coated (Sr-Ti40Nb) and
uncoated (Ti40Nb) Ti-40Nb samples over 21 days. (a) DNA content correlated with the cell number, (b) intracellular LDH activity correlated with
the cell number, (c) specific ALP activity. The cell experiment was performed using triplicates; 2-way analysis of variance (ANOVA) was used to
evaluate statistical significance at a level of p < 0.05. Post-hoc analysis using the Tukey-method was used for multiple comparisons (GraphPad
PRISM 7.02)
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Sr2+ delivery took place and the effect of Sr2+ is low be-
cause of medium change during cultivation and only
minor Sr2+ release after medium change.
Conclusions
Ti-40Nb alloys were successfully plasma coated with a
strontium compound. TEM images of cross sections,
which were prepared by focused ion beam technique, re-
veal dense coating layers of more than 100 nm thickness.
From the results of the applied surface analytical
methods XPS and ToF-SIMS we conclude that the de-
posited layer is a SrOxCly compound. Additionally,
traces of F and Fe were found as contaminations from
the plasma setup. These contaminations can be avoided
in commercial reactors by the use of a special design.
Here larger distances between reactor walls and dis-
charge setup as well as better shielding of the built-in
components can be realised and should avoid cross con-
tamination with materials sputtered from the setup itself.
In vitro release experiments of the coated alloys in aque-
ous saline solutions reveal that Sr2+ is released from
SrOxCly films too fast. However, we achieved concentra-
tions, that are above the pharmaceutical effect threshold.
In cell culture experiments with human osteoblasts a
positive effect of the coating on cell proliferation and
osteogenic differentiation was observed. Nevertheless,
future work will focus on the preparation of thicker
coatings with slower Sr2+ release by the use of other
strontium compounds with lower solubility.
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Abbreviations
ALP: Alkaline phosphatase; ANOVA: Analysis of variance;; DAPI: 4′,6-diamidino-
2-phenylindole; DNA: Deoxyribonucleic acid; EDXS: Energy dispersive X-ray
spectroscopy; EELS: Electron energy loss spectroscopy; FCS: fetal calf serum;;
FIB: Focused ion beam;; hOB: Primary human osteoblasts; HR-TEM: High
resolution transmission electron microscopy; ICP-MS: Inductively coupled
plasma mass spectrometry; LDH: Lactate dehydrogenase; L-glu: L-glutamine;
MFC: Mass flow controller; pen/strep: 100 U/ml penicillin and 100 mg/ml
streptomycin; pNp: p-nitrophenolate; RF: Radio frequency; SDD: Silicon Drift
detector; SEM: Scanning electron microscopy; STEM: Scanning transmission
electron microscopy; TBS: Tris-buffered saline; Ti-40Nb: Titanium-40(weight-
%)niobium; ToF-SIMS: Time of flight secondary ion mass spectrometry;
XPS: X-ray photoelectron spectroscopy; X-ray: X-radiation; α-MEM: Alpha
minimum essential medium
Acknowledgments
The authors thank Jan Bamberger and Dr. Uwe Linne from the core facility
mass spectrometry of University of Marburg for ICP-MS analysis as well as
Dina Bieberstein (IFW Dresden) for the careful preparation of the FIB lamellas.
Funding
This work was funded by the Deutsche Forschungsgemeinschaft (DFG,
Collaborative Research Centre Transregio 79 – subprojects M1, M2, M4, M5
and Z2) and the Justus-Liebig University Giessen in the funding programme
“Open Access Publishing”.
Availability of data and materials
Additional file available in this journal. For request of other data please
contact author.
Authors’ contributions
MG drafted most of the manuscript and designed all experiments together
with MR. YM prepared all SrOxCly film samples by reactive sputtering and
performed the characterization by SEM and ToF-SIMS (together with MR). MS
and AL guided the in vitro experiments and drafted the respective section.
JT and TG guided the TEM analysis and interpreted the results. JS performed
the XPS measurements and drafted the respective section. SP, RS and AG
prepared and characterized the Ti-40Nb material. MR, MG and JJ edited the
manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The ethics commission of Technische Universität Dresden approved the
application of hOB for in vitro experiments (no. EK 262092009). All patients
obtained informed consent.
Consent for publication
The manuscript is being submitted with the consent of all authors.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Institute of Physical Chemistry and Center of Materials Research,
Justus-Liebig-University of Giessen, Heinrich-Buff-Ring 17, 35392, Giessen,
Germany. 2IFW Dresden, Institute for Complex Materials, Helmholtzstrasse 20,
01069 Dresden, Germany. 3Centre for Translational Bone, Joint and Soft
Tissue Research, Faculty of Medicine and University Hospital, Technische
Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
Received: 14 August 2017 Accepted: 28 September 2017
References
1. Van Noort RJ. Titanium: The implant material of today. Mater Sci. 1987;22:
3801–11.
2. Niinomi M, Nakai M. Titanium-Based Biomaterials for Preventing Stress
Shielding between Implant Devices and Bone. Int J Biomater. 2011:1–10.
3. Liu X, Chu PK, Ding C. Surface modification of titanium, titanium alloys, and
related materials for biomedical applications. Mater Sci Eng R. 2004;47:49–121.
4. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J
Obstet Gynecol. 2006;194:S3–S11.
5. Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr
Rheumatol Rep. 2008;10:92–6.
6. Calciolari E, Mardas N, Dereka X, Kostomitsopoulos N, Petrie A, Donos N.
The effect of experimental osteoporosis on bone regeneration: Part 1,
histology findings. Clin Oral Implants Res. 2016;00:1–10.
7. Hanada S, Matsumoto H, Watanabe S. Mechanical compatibility of titanium
implants in hard tissues. Int Cong. Ser. 2005;1284:239–47.
8. Gostin PF, Helth A, Sueptitz R, Calin M, Eckert J, Gebert A. Surface treatment,
corrosion behavior, and apatite-forming ability of Ti-45Nb implant alloy. J Biomed
Mater Res B. 2013;101:269–78.
9. Helth A, Gostin PF, Oswald S, Wendrock H, Wolff U, Hempel U, Arnold S,
Calin M, Eckert J, Gebert A. Chemical nanoroughening of Ti40Nb surfaces
and its effect on human mesenchymal stromal cell response. J Biomed
Mater Res B. 2014;102:31–41.
10. Bonnelye E, Chabadel A, Saltel F, Jurdic P. Dual effect of strontium ranelate:
Stimulation of osteoblast differentiation and inhibition of osteoclast
formation and resorption in vitro. Bone. 2008;42:129–38.
11. Manolagas SC. Cellular and molecular mechanisms of osteoporosis. Aging
Clin Exp Res. 1998;10:182–90.
12. European Medicines Agency. Protelos and Osseor Article-20 procedure -
Protelos/Osseor to remain available but with further restrictions. 2014.
http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_
Göttlicher et al. Biomaterials Research  (2017) 21:18 Page 10 of 11
document/Protelos_and_Osseor/European_Commission_final_decision/
WC500173034.pdf, accessed Aug 19/2016.
13. Xin Y, Jiang J, Huo K, Chu PK. Bioactive SrTiO3 Nanotube Arrays: Strontium
Delivery Platform on Ti-Based Osteoporotic Bone Implant. ACS Nano. 2009;3:
3228–34.
14. Liu C, Zhang Y, Wang L, Zhang X, Chen Q, Wu B. A Strontium-Modified
Titanium Surface Produced by a New Method and Ist Biocompatibility In
Vitro. PLoS One. 2015;10:1–16.
15. Wang Y, Zhang D, Wen C, Li Y. Processing and Characterization of SrTiO3-
TiO2 Nanoparticle-Nanotube Heterostructures on Titanium for Biomedical
Applications. ACS Appl Mater Interfaces. 2015;7:16018–26.
16. Park JW, Kim HK, Kim YJ, Jang JH, Song H, Hanawa T. Osteoblast response
and osseointegration of a Ti-6Al-4V alloy implant incorporating strontium.
Acta Biomater. 2010;6:2843–51.
17. Dang Y, Zhang L, Song W, Chang B, Han T, Zhang Y, Zhao L. vivo
osseointegration of Ti implants with a strontium-containing nanotubular
coating. Int J Nanomedicine. 2016;11:1003–11.
18. Offermanns V, Andersen OZ, Falkensammer G, Andersen IH, Almtoft KP,
Sorensen S, Sillassen M, Jeppesen CS, Rasse M, Foss M, Kloss F. Enhanced
osseointegration of endosseous implants by predictable sustained release
properties of strontium. J Biomed Mater Res, Part B. 2014;103:1099–106.
19. Offermanns V, Andersen OZ, Riede G, Andersen IH, Almtoft KP, Sorensen S,
Sillassen M, Jeppesen CS, Rasse M, Foss M, Kloss F. Bone regenerating effect
of surface-functionalized titanium implants with sustained-release
characteristics of strontium in ovariectomized rats. Int J Nanomedicine.
2016;11:2431–42.
20. Rohnke M, Pfitzenreuter S, Mogwitz B, Henß A, Thomas J, Bieberstein D,
Gemming T, Otto SK, Ray S, Schumacher M, Gelinsky M, Alt V. Strontium
release from Sr2+−loaded bone cements and dissipation in healthy and
osteoporotic rat bone. J Control Release. 2017;262:159–69.
21. Tao ZS, Zhou WS, He XW, Liu W, Bai BL, Zhou Q, Huang ZL, Tu KK, Li H, Sun
T, Lv YX, Cui W, Yang L. A comparative study of zinc, magnesium,
strontium-incorporated hydroxyapatite-coated titanium implants for
osseointegration of osteopenic rats. Mat Sci Eng C. 2016;62:226–32.
22. Yang HW, Lin MH, YZ X, Shang GW, Wang RR, Chen K. Osteogenesis of
bone marrow mesenchymal stem cells on strontium-substituted nano-
hydroxyapatite coated roughened titanium surfaces. Int J Clin Exp Med.
2015;8:257–64.
23. Zhang W, Cao H, Zhang X, Li G, Chang Q, Zhao J, Qiao Y, Ding X, Yang G,
Liu X, Jiang XA. strontium-incorporated nanoporous titanium implant
surface for rapid osseointegration. Nano. 2016;8:5291–301.
24. Meininger M, Wolf-Brandstetter C, Zerweck J, Wenninger F, Gbureck U, Groll
J, Moseke C. Electrochemically assisted deposition of strontium modified
magnesium phosphate on titanium surfaces. Mat Sci Eng C. 2016;67:65–71.
25. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata
J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY.
The effects of strontium ranelate on the risk of vertebral fracture in women
with postmenopausal osteoporosis. N Engl J Med. 2004;350:459–68.
26. Xu K, Chen W, Mu C, Yua Y, Cai K. Strontium folic acid derivative
functionalized titanium surfaces for enhanced osteogenic differentiation of
mesenchymal stem cells in vitro and bone formation in vivo. J Mater Chem
B. 2017;5:6811–26.
27. Xu K, Chen W, Hu Y, Shen X, Xu G, Ran Q, Yu Y, Mu C, Cai K. Influence of
strontium ions incorporated into nanosheet-pore topographical titanium
substrates on osteogenic differentiation of mesenchymal stem cells in vitro
and on osseointegration in vivo. J Mater Chem B. 2016;4:4549–64.
28. Helth A, Pilz S, Kirsten T, Giebeler L, Freudenberger J, Calin M, Eckert J,
Gebert A. Effect of thermomechanical processing on the mechanical
biofunctionality of a low modulus Ti-40Nb alloy. J Mech Beha. Biomed
Mater. 2017;65:137–50.
29. Meiss SA, Rohnke M, Rettig F, Moos R, Janek J. Ion-Conducting Probes for
Low Temperature Plasmas. Contrib Plasma Phy. 2008;48:473–9.
30. Göttlicher M, Rohnke M, Helth A, Leichweiss T, Gemming T, Gebert A, Eckert
J, Janek J. Controlled surface modification of Ti–40Nb implant alloy by
electrochemically assisted inductively coupled RF plasma oxidation. Acta
Biomater. 2013;9:9201–10.
31. Oswald S, Gostin PF, Helth A, Abdi S, Giebeler L, Wendrock H, Calin M,
Eckert J, Gebert A. XPS and AES sputter-depth profiling at surfaces of
biocompatible passivated Ti-based alloys: concentration quantification
considering chemical effects. Surf Interface Anal 2014;46; 683–688.
32. Schumacher M, Lode A, Helth A, Gelinsky MA. novel strontium(II)-modified
calcium phosphate bone cement stimulates human-bone-marrow-derived
mesenchymal stem cell proliferation and osteogenic differentiation in vitro.
Acta Biomater. 2013;9:9547–57.
33. Ding YF, Li RW, Nakai M, Majumdar T, Zhang DH, Niinomi M, Birbilis N,
Smith PN, Chen XB. Osteoanabolic Implant Materials for Orthopedic
Treatment. Adv Healthcare. Mater. 2016;5:1740–52.
34. Zhuravleva K, Bönisch M, Prashanth KG, Hempel U, Helth A, Gemming T,
Calin M, Scudino S, Schultz L, Eckert J, Gebert A. Production of Porous β-
Type Ti-40Nb Alloy for Biomedical Applications: Comparison of Selective
Laser Melting and Hot Pressing. Materials. 2013;6:5700–12.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Göttlicher et al. Biomaterials Research  (2017) 21:18 Page 11 of 11
